Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05332561
Title Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors German Cancer Research Center
Indications

triple-receptor negative breast cancer

Her2-receptor positive breast cancer

Therapies

Olaparib

Ipatasertib

Sacituzumab govitecan-hziy

GDC-0077

Pertuzumab/trastuzumab/hyaluronidase-zzxf

Atezolizumab

Age Groups: senior | adult
Covered Countries DEU

Additional content available in CKB BOOST